Delivery Order SPE2DB20D3103-SPE2DB22FM2T7
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used for diabetes management. The award has a ceiling value of $5,409.60 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 1.5 mg/0.5 ml pens. The award, valued at $19,571.72, is a firm fixed-price delivery order contract with a completion date of September 25, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,902.80, is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a prescription medication used to manage diabetes. The IDC with the DLA, worth up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The award has a ceiling value of $5,613.20 and an ultimate completion date of September 1, 2022. The contract is a firm fixed-price arrangement with no...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $16,755.44 for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a diabetes medication. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 28, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen, a major...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $10,153.55. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, which are used to treat diabetes. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is responsible for providing medical supplies to the U.S. military and other federal agencies. The contract has an ultimate completion date of October 24, 2023 and is a firm...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 1.5 mg/0.5 ml pens. The $4,287.10 firm fixed-price delivery order has an ultimate completion date of April 5, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,977.42 for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a completion date of January 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The award has a ceiling value of $2,704.80 and an ultimate completion date of September 14, 2021. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,906.02, is for the delivery of Trulicity 0.75 mg/0.5 ml pens. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM2T7Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of Trulicity 1.5 mg/0.5 ml pens, which are used to treat diabetes. The award has a ceiling value of $2,211 and a completion date of January 13, 2022. This contract is part of the DLA's efforts to provide essential pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this award, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/12/22 |